nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—Carcinoma of lung—Riluzole—amyotrophic lateral sclerosis	0.0397	0.0459	CcSEcCtD
Doxazosin—Lung neoplasm malignant—Riluzole—amyotrophic lateral sclerosis	0.0344	0.0397	CcSEcCtD
Doxazosin—Subarachnoid haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0316	0.0365	CcSEcCtD
Doxazosin—Donepezil—SIGMAR1—amyotrophic lateral sclerosis	0.0232	1	CrCbGaD
Doxazosin—Gastrointestinal tract irritation—Riluzole—amyotrophic lateral sclerosis	0.0193	0.0223	CcSEcCtD
Doxazosin—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.0185	0.0214	CcSEcCtD
Doxazosin—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.0185	0.0214	CcSEcCtD
Doxazosin—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0147	0.017	CcSEcCtD
Doxazosin—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.0147	0.017	CcSEcCtD
Doxazosin—Priapism—Riluzole—amyotrophic lateral sclerosis	0.0143	0.0165	CcSEcCtD
Doxazosin—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0158	CcSEcCtD
Doxazosin—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0151	CcSEcCtD
Doxazosin—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0146	CcSEcCtD
Doxazosin—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0144	CcSEcCtD
Doxazosin—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0137	CcSEcCtD
Doxazosin—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0135	CcSEcCtD
Doxazosin—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0132	CcSEcCtD
Doxazosin—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.011	0.0127	CcSEcCtD
Doxazosin—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0123	CcSEcCtD
Doxazosin—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0122	CcSEcCtD
Doxazosin—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0118	CcSEcCtD
Doxazosin—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0117	CcSEcCtD
Doxazosin—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00983	0.0114	CcSEcCtD
Doxazosin—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00965	0.0112	CcSEcCtD
Doxazosin—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00956	0.0111	CcSEcCtD
Doxazosin—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00858	0.00991	CcSEcCtD
Doxazosin—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00858	0.00991	CcSEcCtD
Doxazosin—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.0079	0.00913	CcSEcCtD
Doxazosin—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00753	0.0087	CcSEcCtD
Doxazosin—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00743	0.00859	CcSEcCtD
Doxazosin—Gout—Riluzole—amyotrophic lateral sclerosis	0.00738	0.00853	CcSEcCtD
Doxazosin—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00724	0.00837	CcSEcCtD
Doxazosin—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00673	0.00778	CcSEcCtD
Doxazosin—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00666	0.00769	CcSEcCtD
Doxazosin—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00647	0.00748	CcSEcCtD
Doxazosin—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00633	0.00732	CcSEcCtD
Doxazosin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00604	0.00698	CcSEcCtD
Doxazosin—KCNH7—nervous system—amyotrophic lateral sclerosis	0.00602	0.0617	CbGeAlD
Doxazosin—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00598	0.00691	CcSEcCtD
Doxazosin—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00598	0.00691	CcSEcCtD
Doxazosin—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00592	0.0606	CbGeAlD
Doxazosin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00587	0.00678	CcSEcCtD
Doxazosin—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00587	0.00678	CcSEcCtD
Doxazosin—KCNH7—central nervous system—amyotrophic lateral sclerosis	0.0058	0.0594	CbGeAlD
Doxazosin—KCNH7—cerebellum—amyotrophic lateral sclerosis	0.00567	0.058	CbGeAlD
Doxazosin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00559	0.00646	CcSEcCtD
Doxazosin—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00559	0.00646	CcSEcCtD
Doxazosin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00643	CcSEcCtD
Doxazosin—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0054	0.00624	CcSEcCtD
Doxazosin—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00615	CcSEcCtD
Doxazosin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00615	CcSEcCtD
Doxazosin—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00528	0.0061	CcSEcCtD
Doxazosin—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00526	0.00608	CcSEcCtD
Doxazosin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00519	0.006	CcSEcCtD
Doxazosin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00595	CcSEcCtD
Doxazosin—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00592	CcSEcCtD
Doxazosin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.005	0.00578	CcSEcCtD
Doxazosin—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.005	0.00578	CcSEcCtD
Doxazosin—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00496	0.00574	CcSEcCtD
Doxazosin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00493	0.00569	CcSEcCtD
Doxazosin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00493	0.00569	CcSEcCtD
Doxazosin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00558	CcSEcCtD
Doxazosin—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00476	0.0055	CcSEcCtD
Doxazosin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00474	0.00548	CcSEcCtD
Doxazosin—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00471	0.00544	CcSEcCtD
Doxazosin—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00538	CcSEcCtD
Doxazosin—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00534	CcSEcCtD
Doxazosin—KCNH7—brain—amyotrophic lateral sclerosis	0.0046	0.0471	CbGeAlD
Doxazosin—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00457	0.00528	CcSEcCtD
Doxazosin—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00526	CcSEcCtD
Doxazosin—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00455	0.0466	CbGeAlD
Doxazosin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00441	0.0051	CcSEcCtD
Doxazosin—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00503	CcSEcCtD
Doxazosin—KCNH6—nervous system—amyotrophic lateral sclerosis	0.00429	0.0439	CbGeAlD
Doxazosin—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00487	CcSEcCtD
Doxazosin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00481	CcSEcCtD
Doxazosin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00415	0.00479	CcSEcCtD
Doxazosin—KCNH6—central nervous system—amyotrophic lateral sclerosis	0.00413	0.0423	CbGeAlD
Doxazosin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00467	CcSEcCtD
Doxazosin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00467	CcSEcCtD
Doxazosin—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.004	0.00462	CcSEcCtD
Doxazosin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00398	0.0046	CcSEcCtD
Doxazosin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00456	CcSEcCtD
Doxazosin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00394	0.00455	CcSEcCtD
Doxazosin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00452	CcSEcCtD
Doxazosin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00448	CcSEcCtD
Doxazosin—Depression—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00444	CcSEcCtD
Doxazosin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00439	CcSEcCtD
Doxazosin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00437	CcSEcCtD
Doxazosin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00434	CcSEcCtD
Doxazosin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00433	CcSEcCtD
Doxazosin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0037	0.00427	CcSEcCtD
Doxazosin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00425	CcSEcCtD
Doxazosin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00364	0.0042	CcSEcCtD
Doxazosin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00418	CcSEcCtD
Doxazosin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00407	CcSEcCtD
Doxazosin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00401	CcSEcCtD
Doxazosin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00346	0.004	CcSEcCtD
Doxazosin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00398	CcSEcCtD
Doxazosin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00397	CcSEcCtD
Doxazosin—KCNH6—brain—amyotrophic lateral sclerosis	0.00328	0.0336	CbGeAlD
Doxazosin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00374	CcSEcCtD
Doxazosin—Chills—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00359	CcSEcCtD
Doxazosin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00357	CcSEcCtD
Doxazosin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00353	CcSEcCtD
Doxazosin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00303	0.0035	CcSEcCtD
Doxazosin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00348	CcSEcCtD
Doxazosin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00343	CcSEcCtD
Doxazosin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00342	CcSEcCtD
Doxazosin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00341	CcSEcCtD
Doxazosin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00338	CcSEcCtD
Doxazosin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00337	CcSEcCtD
Doxazosin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00335	CcSEcCtD
Doxazosin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00326	CcSEcCtD
Doxazosin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00323	CcSEcCtD
Doxazosin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0032	CcSEcCtD
Doxazosin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00314	CcSEcCtD
Doxazosin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00313	CcSEcCtD
Doxazosin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00312	CcSEcCtD
Doxazosin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00312	CcSEcCtD
Doxazosin—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00268	0.0274	CbGeAlD
Doxazosin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00308	CcSEcCtD
Doxazosin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00306	CcSEcCtD
Doxazosin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00304	CcSEcCtD
Doxazosin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00302	CcSEcCtD
Doxazosin—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00261	0.0267	CbGeAlD
Doxazosin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00301	CcSEcCtD
Doxazosin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00296	CcSEcCtD
Doxazosin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00296	CcSEcCtD
Doxazosin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00296	CcSEcCtD
Doxazosin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00295	CcSEcCtD
Doxazosin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00293	CcSEcCtD
Doxazosin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00251	0.0029	CcSEcCtD
Doxazosin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00287	CcSEcCtD
Doxazosin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00284	CcSEcCtD
Doxazosin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00282	CcSEcCtD
Doxazosin—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00243	0.0249	CbGeAlD
Doxazosin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00242	0.0028	CcSEcCtD
Doxazosin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00278	CcSEcCtD
Doxazosin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00277	CcSEcCtD
Doxazosin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00276	CcSEcCtD
Doxazosin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00275	CcSEcCtD
Doxazosin—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00238	0.0243	CbGeAlD
Doxazosin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00271	CcSEcCtD
Doxazosin—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00234	0.024	CbGeAlD
Doxazosin—ORM1—spinal cord—amyotrophic lateral sclerosis	0.00232	0.0238	CbGeAlD
Doxazosin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00266	CcSEcCtD
Doxazosin—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00229	0.0234	CbGeAlD
Doxazosin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00259	CcSEcCtD
Doxazosin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00257	CcSEcCtD
Doxazosin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00255	CcSEcCtD
Doxazosin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00253	CcSEcCtD
Doxazosin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00253	CcSEcCtD
Doxazosin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00217	0.0025	CcSEcCtD
Doxazosin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00247	CcSEcCtD
Doxazosin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00245	CcSEcCtD
Doxazosin—Pain—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00243	CcSEcCtD
Doxazosin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00243	CcSEcCtD
Doxazosin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00234	CcSEcCtD
Doxazosin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00232	CcSEcCtD
Doxazosin—ORM1—nervous system—amyotrophic lateral sclerosis	0.00196	0.02	CbGeAlD
Doxazosin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00226	CcSEcCtD
Doxazosin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00225	CcSEcCtD
Doxazosin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00225	CcSEcCtD
Doxazosin—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00188	0.0193	CbGeAlD
Doxazosin—ADRA1B—brain—amyotrophic lateral sclerosis	0.00186	0.019	CbGeAlD
Doxazosin—ADRA1D—brain—amyotrophic lateral sclerosis	0.00182	0.0186	CbGeAlD
Doxazosin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00209	CcSEcCtD
Doxazosin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00204	CcSEcCtD
Doxazosin—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.00175	0.018	CbGeAlD
Doxazosin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00201	CcSEcCtD
Doxazosin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00194	CcSEcCtD
Doxazosin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00188	CcSEcCtD
Doxazosin—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.00156	0.016	CbGeAlD
Doxazosin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00181	CcSEcCtD
Doxazosin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00179	CcSEcCtD
Doxazosin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00179	CcSEcCtD
Doxazosin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00178	CcSEcCtD
Doxazosin—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00153	0.0157	CbGeAlD
Doxazosin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00169	CcSEcCtD
Doxazosin—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00138	0.0141	CbGeAlD
Doxazosin—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00137	0.014	CbGeAlD
Doxazosin—KCNH2—nervous system—amyotrophic lateral sclerosis	0.00132	0.0135	CbGeAlD
Doxazosin—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00131	0.0135	CbGeAlD
Doxazosin—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00128	0.0132	CbGeAlD
Doxazosin—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.00127	0.013	CbGeAlD
Doxazosin—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.00124	0.0127	CbGeAlD
Doxazosin—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00123	0.0126	CbGeAlD
Doxazosin—ABCB1—embryo—amyotrophic lateral sclerosis	0.0012	0.0123	CbGeAlD
Doxazosin—ADRA1A—brain—amyotrophic lateral sclerosis	0.00104	0.0107	CbGeAlD
Doxazosin—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00104	0.0106	CbGeAlD
Doxazosin—KCNH2—brain—amyotrophic lateral sclerosis	0.00101	0.0103	CbGeAlD
Doxazosin—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000999	0.0102	CbGeAlD
Doxazosin—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000977	0.01	CbGeAlD
Doxazosin—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000804	0.00823	CbGeAlD
Doxazosin—ADRA2A—brain—amyotrophic lateral sclerosis	0.000793	0.00813	CbGeAlD
Doxazosin—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000774	0.00793	CbGeAlD
Doxazosin—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00077	0.00788	CbGeAlD
Doxazosin—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000757	0.00775	CbGeAlD
Doxazosin—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000686	0.00703	CbGeAlD
Doxazosin—CYP2D6—brain—amyotrophic lateral sclerosis	0.000615	0.00629	CbGeAlD
Doxazosin—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000578	0.00592	CbGeAlD
Doxazosin—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000557	0.0057	CbGeAlD
Doxazosin—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000544	0.00557	CbGeAlD
Doxazosin—ABCB1—brain—amyotrophic lateral sclerosis	0.000442	0.00453	CbGeAlD
Doxazosin—KCNH7—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000265	0.0194	CbGpPWpGaD
Doxazosin—KCNH6—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000253	0.0185	CbGpPWpGaD
Doxazosin—KCNH6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000253	0.0185	CbGpPWpGaD
Doxazosin—KCNH7—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000248	0.0181	CbGpPWpGaD
Doxazosin—KCNH7—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000243	0.0177	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000236	0.0172	CbGpPWpGaD
Doxazosin—KCNH6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000226	0.0165	CbGpPWpGaD
Doxazosin—KCNH7—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000226	0.0165	CbGpPWpGaD
Doxazosin—KCNH7—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000226	0.0165	CbGpPWpGaD
Doxazosin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000222	0.0162	CbGpPWpGaD
Doxazosin—KCNH7—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000201	0.0147	CbGpPWpGaD
Doxazosin—ADRA1B—LPA receptor mediated events—MAPT—amyotrophic lateral sclerosis	0.000161	0.0118	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000152	0.0111	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000152	0.0111	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000152	0.0111	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000126	0.00921	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000116	0.0085	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000112	0.00821	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000103	0.00751	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—CHAT—amyotrophic lateral sclerosis	9.55e-05	0.00698	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	9.55e-05	0.00698	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	8.51e-05	0.00622	CbGpPWpGaD
Doxazosin—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	8.29e-05	0.00606	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	7.87e-05	0.00575	CbGpPWpGaD
Doxazosin—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	7.63e-05	0.00557	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	7.18e-05	0.00525	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	6.84e-05	0.005	CbGpPWpGaD
Doxazosin—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.52e-05	0.00476	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	6.46e-05	0.00472	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	6.27e-05	0.00458	CbGpPWpGaD
Doxazosin—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.9e-05	0.00431	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	5.58e-05	0.00408	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	5.48e-05	0.00401	CbGpPWpGaD
Doxazosin—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.43e-05	0.00397	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	5.4e-05	0.00395	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	5.34e-05	0.0039	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	5.21e-05	0.0038	CbGpPWpGaD
Doxazosin—KCNH7—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	4.86e-05	0.00355	CbGpPWpGaD
Doxazosin—ADRA1B—LPA receptor mediated events—CASP3—amyotrophic lateral sclerosis	4.79e-05	0.0035	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	4.78e-05	0.00349	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	4.62e-05	0.00338	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.54e-05	0.00332	CbGpPWpGaD
Doxazosin—ADRA1B—LPA receptor mediated events—MMP9—amyotrophic lateral sclerosis	4.53e-05	0.00331	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	4.41e-05	0.00322	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	4.3e-05	0.00314	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.16e-05	0.00304	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	3.96e-05	0.0029	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	3.93e-05	0.00287	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	3.9e-05	0.00285	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.86e-05	0.00282	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	3.84e-05	0.0028	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	3.72e-05	0.00272	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	3.7e-05	0.0027	CbGpPWpGaD
Doxazosin—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.68e-05	0.00269	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.63e-05	0.00265	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	3.52e-05	0.00257	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	3.5e-05	0.00256	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—RAB5A—amyotrophic lateral sclerosis	3.44e-05	0.00251	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	3.34e-05	0.00244	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PFN1—amyotrophic lateral sclerosis	3.33e-05	0.00243	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	3.27e-05	0.00239	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.2e-05	0.00233	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	3.12e-05	0.00228	CbGpPWpGaD
Doxazosin—ADRA1B—AMPK Signaling—TP53—amyotrophic lateral sclerosis	2.89e-05	0.00211	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—TPK1—amyotrophic lateral sclerosis	2.86e-05	0.00209	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—VAPB—amyotrophic lateral sclerosis	2.86e-05	0.00209	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	2.8e-05	0.00205	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.74e-05	0.002	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.71e-05	0.00198	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	2.7e-05	0.00197	CbGpPWpGaD
Doxazosin—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.64e-05	0.00193	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—VAPA—amyotrophic lateral sclerosis	2.61e-05	0.00191	CbGpPWpGaD
Doxazosin—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.6e-05	0.0019	CbGpPWpGaD
Doxazosin—ADRA1A—AMPK Signaling—TP53—amyotrophic lateral sclerosis	2.57e-05	0.00188	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.49e-05	0.00182	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.45e-05	0.00179	CbGpPWpGaD
Doxazosin—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.43e-05	0.00177	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.43e-05	0.00177	CbGpPWpGaD
Doxazosin—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.4e-05	0.00175	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	2.36e-05	0.00172	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.31e-05	0.00169	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—FIG4—amyotrophic lateral sclerosis	2.28e-05	0.00167	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.28e-05	0.00167	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.27e-05	0.00166	CbGpPWpGaD
Doxazosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.26e-05	0.00165	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	2.24e-05	0.00164	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.18e-05	0.00159	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.08e-05	0.00152	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—DAO—amyotrophic lateral sclerosis	2.06e-05	0.00151	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.06e-05	0.0015	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.03e-05	0.00149	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.02e-05	0.00148	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.02e-05	0.00148	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.02e-05	0.00147	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	1.99e-05	0.00145	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.98e-05	0.00144	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.98e-05	0.00144	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.96e-05	0.00143	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.91e-05	0.0014	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	1.91e-05	0.00139	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.89e-05	0.00138	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	1.88e-05	0.00137	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	1.86e-05	0.00136	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	1.86e-05	0.00136	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.85e-05	0.00135	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	1.85e-05	0.00135	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	1.81e-05	0.00132	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.81e-05	0.00132	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.8e-05	0.00131	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.75e-05	0.00128	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.75e-05	0.00128	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.73e-05	0.00126	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.72e-05	0.00126	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.7e-05	0.00124	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.7e-05	0.00124	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.68e-05	0.00123	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	1.68e-05	0.00123	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.65e-05	0.0012	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.62e-05	0.00118	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—SOD1—amyotrophic lateral sclerosis	1.61e-05	0.00118	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.59e-05	0.00116	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.58e-05	0.00116	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.58e-05	0.00115	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PLB1—amyotrophic lateral sclerosis	1.56e-05	0.00114	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.56e-05	0.00114	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.54e-05	0.00112	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.49e-05	0.00109	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.49e-05	0.00109	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.48e-05	0.00108	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.46e-05	0.00107	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.46e-05	0.00107	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.45e-05	0.00106	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	1.44e-05	0.00106	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSR—amyotrophic lateral sclerosis	1.44e-05	0.00106	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.43e-05	0.00104	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.43e-05	0.00104	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.41e-05	0.00103	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.41e-05	0.00103	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.37e-05	0.001	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.35e-05	0.000983	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.32e-05	0.000967	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.31e-05	0.000956	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.26e-05	0.000917	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	1.24e-05	0.000909	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.23e-05	0.000899	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.23e-05	0.000897	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.22e-05	0.000888	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.22e-05	0.000888	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.21e-05	0.000884	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.2e-05	0.000878	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	1.19e-05	0.000867	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.18e-05	0.000861	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.17e-05	0.000852	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.14e-05	0.000833	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.13e-05	0.000825	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.11e-05	0.00081	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.08e-05	0.000791	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.08e-05	0.000789	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.07e-05	0.000782	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.07e-05	0.00078	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.02e-05	0.000748	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.02e-05	0.000745	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1e-05	0.000734	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1e-05	0.000733	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	9.99e-06	0.00073	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.95e-06	0.000727	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.92e-06	0.000725	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	9.82e-06	0.000718	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.78e-06	0.000714	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	9.67e-06	0.000707	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	9.41e-06	0.000688	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.33e-06	0.000682	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.32e-06	0.000681	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	8.92e-06	0.000652	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.89e-06	0.000649	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.88e-06	0.000649	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	8.68e-06	0.000635	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	8.4e-06	0.000614	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	8.29e-06	0.000606	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.26e-06	0.000603	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.2e-06	0.000599	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	8.07e-06	0.00059	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.89e-06	0.000576	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.74e-06	0.000566	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	7.73e-06	0.000565	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.67e-06	0.00056	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.61e-06	0.000556	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.37e-06	0.000539	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.33e-06	0.000536	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.33e-06	0.000535	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	7.31e-06	0.000534	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.15e-06	0.000522	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.88e-06	0.000503	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.81e-06	0.000498	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.55e-06	0.000479	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	6.42e-06	0.000469	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.39e-06	0.000467	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.37e-06	0.000466	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.32e-06	0.000462	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.31e-06	0.000461	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.09e-06	0.000445	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.93e-06	0.000434	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.88e-06	0.00043	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.86e-06	0.000428	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.61e-06	0.00041	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.27e-06	0.000385	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.25e-06	0.000384	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.25e-06	0.000383	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.21e-06	0.000381	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.9e-06	0.000358	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.88e-06	0.000357	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.86e-06	0.000355	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	4.85e-06	0.000354	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	4.82e-06	0.000352	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.66e-06	0.00034	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.52e-06	0.00033	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.41e-06	0.000322	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.34e-06	0.000317	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.33e-06	0.000316	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.15e-06	0.000303	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.15e-06	0.000303	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.05e-06	0.000296	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.03e-06	0.000295	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.03e-06	0.000294	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.82e-06	0.000279	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.74e-06	0.000273	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.58e-06	0.000262	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.54e-06	0.000258	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.41e-06	0.000249	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.33e-06	0.000243	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.33e-06	0.000243	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.3e-06	0.000241	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.18e-06	0.000232	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.14e-06	0.000229	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.11e-06	0.000227	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.94e-06	0.000214	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.76e-06	0.000202	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.64e-06	0.000193	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.61e-06	0.00019	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.56e-06	0.000187	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.42e-06	0.000177	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.4e-06	0.000175	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.34e-06	0.000171	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.34e-06	0.000171	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.28e-06	0.000167	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.18e-06	0.000159	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.15e-06	0.000157	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.99e-06	0.000145	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.77e-06	0.000129	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.64e-06	0.00012	CbGpPWpGaD
